---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-080474"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2023-03-27T23:59:59+00:00"
generated_at: "2026-06-17T15:17:54.926156+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical appoints Robert McNamara to board, sets 2023 annual meeting

## Summary
- Robert McNamara appointed to Board of Directors effective April 1, 2023.
- McNamara receives $70K annual cash, $210K initial equity, $105K annual equity (subject to shareholder approval).
- McNamara has 25+ years of med-tech leadership; currently on boards of Axonics, Teknova, Xtant Medical.
- 2023 Annual Meeting scheduled for June 6, 2023 via live audio webcast.

## SEC filing metadata
- accession: 0001193125-23-080474
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2023-03-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000119312523080474/0001193125-23-080474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000119312523080474/d468715d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-080474
- JSON: https://secwatch.observer/filing/0001193125-23-080474.json
- Plain text: https://secwatch.observer/filing/0001193125-23-080474.txt

## Key facts
- Executive change
  Robert McNamara was appointed as Board of Directors at AVITA Medical, Inc..
  - Action: appointed
  - Role: Board of Directors
  source text: On March 23, 2023, AVITA Medical, Inc. (the “Company”) issued a press release announcing the appointment of Robert McNamara to its Board of Directors (the “Board”), effective April 1, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1762303/000119312523080474/0001193125-23-080474-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.